LifeMD is a fast-growing, profitable telehealth company with strong partnerships. Click here to read why LFMD stock is a Buy.

When asked today if Ireland will follow such a move, the health minister said Mounjaro, “is going through the reimbursement ...

Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...

Guselkumab, whether administered every 4 or 8 weeks, demonstrates “significant inhibition” of structural damage in patients ...

DelveInsight's BAFF- and APRIL-targeted Therapies Market Size, Target Population, Competitive Landscape & Market Forecast ...

Evangeline Lilly has cancelled an appearance at the Italian Global Series Festival (IGSF) for health reasons. The star, who ...

The stock market rose within a mini-range for the week amid Israel-Iran headlines and the Federal Reserve's rate outlook.

Phase 2a data on Skye Bioscience's (NASDAQ:SKYE) cannabinoid-1 receptor blocker (CB1) for obesity, nimacimab, should be ...

While there is still some uncertainty in the market related to tariffs, the U.S. economy, and a new conflict in the Middle ...

Eli Lilly has agreed to acquire cardiovascular disease treatment specialist Verve Therapeutics in a deal potentially rising ...

FacebookTweetPin The prospects of a ceasefire in the Middle East have dimmed after a series of comments by President Donald [ ...

John Wiley & Sons Inc. WLY) on Tuesday reported net income of $68.1 million in its fiscal fourth quarter. The Hoboken, New Jersey-based company said it had profit of $1.25 per share.